Senseonics Holdings Inc (NYSEAMERICAN:SENS)’s share price was up 7.9% during trading on Thursday . The company traded as high as $2.34 and last traded at $2.19. Approximately 2,746,671 shares changed hands during mid-day trading, an increase of 51% from the average daily volume of 1,816,305 shares. The stock had previously closed at $2.03.
SENS has been the topic of several research reports. Piper Jaffray Companies initiated coverage on Senseonics in a research note on Tuesday, January 29th. They set a “neutral” rating on the stock. Zacks Investment Research lowered Senseonics from a “hold” rating to a “sell” rating in a research note on Wednesday, January 30th. Two research analysts have rated the stock with a sell rating, one has given a hold rating and five have given a buy rating to the stock. The company currently has an average rating of “Hold” and a consensus target price of $6.00.
Senseonics (NYSEAMERICAN:SENS) last issued its quarterly earnings results on Tuesday, March 12th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.11. The firm had revenue of $7.20 million for the quarter, compared to the consensus estimate of $7.89 million.
COPYRIGHT VIOLATION NOTICE: This piece of content was published by WKRB News and is the sole property of of WKRB News. If you are accessing this piece of content on another site, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this piece of content can be accessed at https://www.wkrb13.com/2019/04/11/senseonics-sens-trading-up-7-9.html.
About Senseonics (NYSEAMERICAN:SENS)
Senseonics Holdings, Inc, a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days.
Recommended Story: Marijuana Stocks Future Looks Bright
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.